March 10, 2026 – 9 min read
By Sheri Weppel, Performance Development Group
The short answer: AI coaching tools for pharma sales are most valuable when they support human coaches and provide scale to coaching — scoring roleplays, analyzing call recordings, prompting rep self-reflection — so managers can focus coaching conversations to create impact rather than data collection. They surface patterns. They draw conclusions based on the information they are given. But without the full picture they cannot explain them. The organizations getting real results designed the coaching system before they deployed the tool.
Eighty-four percent of leaders say they’re actively coaching their people. Only 14 percent of employees say that coaching adds any value — a gap documented by researchers at Forrester and echoed across PDG’s work with pharma commercial teams. That gap existed before AI entered the picture and AI coaching tools for pharma sales teams are now being deployed at scale without closing it.
Most organizations are using AI to demonstrate that something is happening. Dashboards light up. Completion rates tick up. Nobody asks whether the coaching conversations themselves got any better. That’s the trap: mistaking participation for impact.
The organizations getting genuine value from AI in coaching are the ones that designed the coaching system first and then asked how AI could make it better.
The honest answer to “what can AI do for coaching?” starts with the work that was eating coaching time before the tool arrived.
First line leaders in pharma carry spans of control that make meaningful individual coaching nearly impossible at scale. Before AI, a pharma sales manager’s visibility into a rep’s actual skill level came down to a ride-along, maybe once a quarter, with whatever interactions happened to surface that day. One call, potentially unrepresentative, became the entire basis for a coaching conversation.
AI changes that data problem. Roleplay tools can act as the HCP, score compliance against approved language, and give reps structured feedback on whether they included every required step before they’re ever in front of a physician. Video reflection tools let reps record a short recap immediately after an interaction, while the details are still fresh, and receive analysis on structure, pacing, and question quality. Call recording tools track the ratio of talking to listening, whether questions were open or closed, whether action-oriented statements were made, even eye contact and intonation.
All of it is admin work that used to eat coaching time. Now it generates a broader comprehensive dataset that makes coaching precise.
The analogy that clarifies it: think of a person logging their food and exercise in an app every day. The app gives immediate feedback — calories, macros, patterns. Useful. But the real work happens when they meet with a dietitian, who looks at the rolled-up data across weeks, identifies the undercurrents, and asks the questions the app can’t: why are you skipping breakfast on Tuesdays? You seem to be eating out a lot, how can we make healthier choices?
When it works, it looks like this: instead of reacting to a single ride-along, a manager arrives at a coaching conversation with AI roleplay data, live observation notes, and a rep’s own self-reflection. Themes emerge across all three: clinical conviction isn’t coming across, or the questioning is consistently weak. The manager has direction before the conversation starts. The rep isn’t surprised by the feedback. The coaching is specific and actionable.
The substitution trap is what happens when an organization deploys AI coaching tools as a replacement for coaching accountability infrastructure, rather than as a support for it. The result is better-documented bad coaching — the data exists, but nothing changes.
Here’s the failure mode I see most consistently: organizations implement AI coaching tools without fixing the accountability infrastructure underneath.
The pattern has a recognizable shape. Executive declares a “culture of coaching” at the POA meeting. AI tool gets deployed as evidence of that commitment. The field is now completing roleplays and recording reflections. L&D considers it a success because there’s finally a system in place. Meanwhile, sales leadership is still asking whether any of this is actually changing what happens in front of physicians. Nobody is sure. Nobody is looking at the data closely enough to know.
Organizations under pressure to “leverage AI” are deploying tools without defining what specific problem the tool is supposed to solve, how it integrates into existing workflows, what the before-and-after looks like, or how managers’ roles need to change in response to the new data they’re receiving. Managers suddenly have 60 or more new data points and no guidance on what to prioritize or what to do next. The field puts in the work. The data sits untouched. That’s a sales coaching accountability problem, not a technology problem. Nothing changes.
AI is the diagnostics. The coach is the physician — the one who looks at the results, considers the full patient history, and decides what the treatment plan actually is.
AI can tell you what happened in a simulation of a call. It cannot tell you why. The technical checklist AI handles well: did the rep follow the script, use the required efficacy language, maintain appropriate eye contact, ask questions rather than monologue? These are measurable, and AI measures them. They’re also incomplete.
The conversation intelligence platforms and AI roleplay tools on the market today are genuinely strong at scoring behavioral compliance. Coaches need discernment in how they use that output — and the word “discernment” is deliberate. AI can over-index or under-index on factors it wasn’t built to contextualize. A rep with a physical tic might score poorly on eye contact behaviors not because of skill failure but because of a factor the tool can’t account for. A rep navigating a physician personality that didn’t match the AI’s practice persona might show low engagement scores that have nothing to do with their capability. The score is what it is. The context is human.
More fundamentally: when AI surfaces that a rep’s clinical conviction isn’t landing, it cannot tell you why. Is it that the rep doesn’t believe the data? That they don’t understand it deeply enough? That they fear the pushback and hedge? That they have so much product detail in their head that they don’t know what to lead with? Each of those is a different coaching problem, and getting to the real one requires a conversation — a real one, where the coach listens long enough to find it.
That’s the boundary AI doesn’t cross. It surfaces the pattern. The coach determines what it means and what to do about it.
This matters beyond coaching quality. When AI data and field observation aren’t deliberately integrated, performance documentation becomes fragile. A manager who documents a concern based on AI scores alone — without reconciling what the tool surfaced against what they personally observed in the field — is building on an incomplete record. Neither data stream is sufficient on its own. The organizations getting this right treat them as two inputs that must be read together.
The right way to implement AI coaching tools in pharma sales is to design the coaching system first — define what good looks like, establish the manager’s role in interpreting AI output, and build accountability for what happens after the data is generated — then deploy the tool into that system. Organizations that reverse this sequence get adoption without impact.
The organizations getting end-to-end value from AI in coaching have built it into an architecture where every phase feeds the next.
It starts with leaders — not with the field. Before reps are asked to practice in an AI environment, managers need to be coached on what good looks like, what the AI will surface, and how to use that data in a coaching conversation. If managers don’t understand the tool, they won’t trust the output. If they don’t trust the output, they won’t use it. The technology dies before it starts.
That preparation isn’t a briefing — it’s a co-creation process. Leaders at every level need to understand why the organization is making this investment, not just that it’s happening. They need to be involved in developing the scenarios the tool will use, so the practice environment reflects the actual conversations their teams are having. They need enough time with the tool to form a genuine opinion about its value before it lands in their reps’ hands. The organizations that skip this step — that brief managers three days before the field launch — are not implementing AI coaching. They’re creating skeptics at the level where buy-in matters most. If the leader doesn’t believe in it, the rep won’t either.
From there: field training on the core skills being developed, followed by digital reinforcement pushed into the flow of work. AI roleplay for practice between live interactions — creating coaching experiences that typically only existed at national meetings or manager ride-alongs. AI video feedback for reflection immediately after interactions. All of it feeding into a periodic coaching touchpoint, where the manager has aggregated data rather than a single snapshot.
The skill most organizations don’t explicitly train is how to read AI data and field observation together. A manager who reviews AI roleplay scores before a ride-along arrives with hypotheses, not a blank observation form. The field visit becomes a test: does what I see confirm what the data flagged, or does it complicate it? When they align, the coaching conversation is specific and grounded. When they diverge, that divergence is itself diagnostic — worth exploring with the rep rather than resolving unilaterally.
That’s the missed opportunity most organizations are sitting on: the tool is deployed as a practice space, and the data it generates sits unused as a driver of targeted coaching.
Tools don’t create capability. Systems do. The managers who are getting value from AI are using it to coach with precision instead of guesswork — to walk into a conversation already knowing what to focus on, which questions to ask, and where the real development gap lives. Stop asking whether your managers are using the AI. Start asking whether their coaching conversations are getting better. Those are different questions. Only one tells you whether your investment is working.
Sheri Weppel leads learning and development strategy at Performance Development Group, where she guides AI coaching implementations across pharma commercial organizations. PDG works exclusively with pharmaceutical and biotech companies to close the gap between training and sustained field behavior.
Physicians restrict access to reps who waste their time. Discover the coaching approach that transforms 30-second hallway interactions into valuable conversations that earn more access.
Life Sciences Making the Case for Measurement in Life Science Sales Life science organizations measure a lot of things—but are they measuring the right things? Despite the industry’s emphasis on precision, many sales leaders still hesitate when it comes to performance measurement. It’s not that measurement isn’t happening; it’s that what they’re measuring is often disconnected from […]
